| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.16 | 0.0002 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.14 | 0.0007 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.094 | 0.03 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.091 | 0.05 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.083 | 0.07 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.077 | 0.09 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.067 | 0.1 |